Listen to Rob Davidson, CEO of CURE Pharmaceutical and corporate board member for several companies in the industry, discuss this niche in the pharma world.
“A publicly traded company, focusing on the delivery system of medications, with systems offering less toxicology and fewer side effects. With a proprietary system, they offer a delivery system that is unique and is not processed through the stomach.”
Hear the full podcast below.
